πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

108 results for β€œXin” Clear

  1. omacetaxine mepesuccinate

    Teva Pharma GmbH

    Hematologic Malignancies

    phase 1 small molecule completed

    1 trial
  2. Anshen Buxin Liuwei Pill

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cardiac Neurosis

    approved small molecule active

    1 trial
  3. Botulinum Toxin A

    United Therapeutics Europe Ltd

    Low Back Pain

    approved small molecule terminated

    1 trial
  4. Botulinum Toxin Type B

    SUPERNUS PHARMACEUTICALS, INC.

    Cervical Dystonia

    approved mab completed

    1 trial
  5. DIGOXIN

    Disc Medicine

    heart failure

    approved small molecule active

    1 trial
  6. Desvenlafaxine Succinate

    Grace Therapeutics

    Vascular Depression

    approved small molecule active

    1 trial
  7. Dexamethasone

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Localized Primary Osteoarthritis of Both Hips (Diagnosis)

    approved small molecule active

    1 trial
  8. Digaoxin,amiodarone,Ξ² receptor antagonist, Calcium Antagonists

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atrial Fibrillation

    approved small molecule active

    1 trial
  9. Digoxin

    Teva Pharma GmbH

    Heart Failure

    approved small molecule completed

    1 trial
  10. Hepatitis B vaccine

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Hepatitis B Vaccination, HIV

    approved mab active

    1 trial
  11. Levothyroxine

    United Therapeutics Europe Ltd

    Hypothyroidism

    approved small molecule completed

    1 trial
  12. Levothyroxine

    The First People's Hospital of Lianyungang

    Heart Failure

    approved small molecule active

    1 trial
  13. SILDENAFIL , LEVOTHYROXINE SODIUM

    The George Institute

    erectile function, hypothyroidism subclinic

    approved small molecule active

    1 trial
  14. Shexiang Baoxin pill

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Disease(CAD)

    approved small molecule active

    1 trial
  15. Shexiang Baoxin pill(MUSKARDIAοΌ‰

    Disc Medicine

    Ischemia With Non-Obstructive Coronary Artery

    approved other completed

    1 trial
  16. Sulfadoxine-pyrimethamine

    United Therapeutics Europe Ltd

    Malaria (Uncomplicated)

    approved small molecule completed

    1 trial
  17. Topiramate

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Alcohol Dependence

    approved small molecule active

    1 trial
  18. VENLAFAXINE

    Disc Medicine

    Major Depressive Disorder

    approved small molecule active

    1 trial
  19. Wen Xin granule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Heart Disease

    approved small molecule active

    1 trial
  20. Xingnaojing injection

    The First People's Hospital of Lianyungang

    Ischemic Stroke, Acute

    approved small molecule active

    1 trial
  21. Xingnaojing injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Ischemic Stroke

    approved small molecule active

    1 trial
  22. Xingnaojing injection

    Universal Integrated

    Acute Ischemic Stroke

    approved small molecule active

    1 trial
  23. Xinnaoning Capsule

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Stable Angina Pectoris

    approved small molecule active

    1 trial
  24. Xueshuanxinmaining tablet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Heart Disease

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources